AR060104A1 - Modulacion de la formacion de huesos - Google Patents
Modulacion de la formacion de huesosInfo
- Publication number
- AR060104A1 AR060104A1 ARP070100684A ARP070100684A AR060104A1 AR 060104 A1 AR060104 A1 AR 060104A1 AR P070100684 A ARP070100684 A AR P070100684A AR P070100684 A ARP070100684 A AR P070100684A AR 060104 A1 AR060104 A1 AR 060104A1
- Authority
- AR
- Argentina
- Prior art keywords
- ror2
- bone
- modulation
- bone formulation
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/108—Osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Modulacion de la actividad de Ror (p. ej., la actividad de la proteína Ror2) y/o 14-3-3b para producir un efecto sobre la formacion o resorcion osea. Composiciones y métodos para el rastreo, el diagnostico y el desarrollo de terapias para trastornos relacionados con los huesos tales como osteoporosis y fractura de huesos. Los anticuerpos y fragmentos de anticuerpos dirigidos a la proteína Ror2 son particularmente utiles para producir dimerizacion de las proteínas Ror2, generando con ello la activacion de Ror2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77453406P | 2006-02-17 | 2006-02-17 | |
US84423906P | 2006-09-13 | 2006-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR060104A1 true AR060104A1 (es) | 2008-05-28 |
Family
ID=38437973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070100684A AR060104A1 (es) | 2006-02-17 | 2007-02-16 | Modulacion de la formacion de huesos |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090047287A1 (es) |
EP (1) | EP1984395A2 (es) |
JP (1) | JP2009527485A (es) |
KR (1) | KR20080095269A (es) |
AR (1) | AR060104A1 (es) |
AU (1) | AU2007217779A1 (es) |
BR (1) | BRPI0707864A2 (es) |
CA (1) | CA2638803A1 (es) |
CR (1) | CR10212A (es) |
EC (1) | ECSP088682A (es) |
IL (1) | IL193271A0 (es) |
MX (1) | MX2008010511A (es) |
NO (1) | NO20083497L (es) |
PA (1) | PA8715601A1 (es) |
PE (1) | PE20071309A1 (es) |
RU (1) | RU2008131052A (es) |
SV (1) | SV2009002997A (es) |
TW (1) | TW200800266A (es) |
WO (1) | WO2007098198A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130079246A1 (en) * | 2010-05-05 | 2013-03-28 | Addex Pharma Sa | Methods and Tools for Screening Agents Exhibiting an Activity on Receptors of the Tumor Necrosis Factor Receptor Superfamily |
WO2013070033A1 (ko) * | 2011-11-09 | 2013-05-16 | 주식회사 아이엠헬스케어 | 골다공증 및 골회전율 진단 스트립 |
KR101354826B1 (ko) * | 2011-12-08 | 2014-01-27 | 아주대학교산학협력단 | 중간엽줄기세포 렙틴분비능을 이용한 골다공증 예방 또는 치료용 물질 스크리닝 방법 |
EP2800975A4 (en) * | 2012-01-03 | 2015-12-09 | Univ Leland Stanford Junior | ANALYSIS AND TARGETING OF ROR2 IN CANCER |
JP6463029B2 (ja) * | 2013-08-02 | 2019-01-30 | 有未 伊谷 | ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び/または品質評価を行う方法 |
SG11201610795VA (en) * | 2014-08-01 | 2017-02-27 | Purec Co Ltd | Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method |
WO2017022628A1 (ja) * | 2015-07-31 | 2017-02-09 | 国立大学法人大阪大学 | 上皮疾患に対する治療及び/又は予防有効性を評価する方法、上皮疾患治療剤のスクリーニング方法、及び上皮疾患治療剤 |
AU2017263568B2 (en) * | 2016-05-13 | 2024-01-18 | Bioatla, Llc | Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof |
GB201718985D0 (en) | 2017-11-16 | 2018-01-03 | Univ London Queen Mary | Treatment |
US11793452B2 (en) | 2019-10-03 | 2023-10-24 | Johnson & Johnson Consumer Inc. | Method of visualizing and quantifying remineralization |
CN115786252B (zh) * | 2023-02-07 | 2023-05-05 | 赛德特生物制药有限公司 | 人脐带间充质干细胞成骨诱导分化培养基及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312814A (en) * | 1992-12-09 | 1994-05-17 | Bristol-Myers Squibb Co. | α-phosphonocarboxylate squalene synthetase inhibitors |
AU2001238571A1 (en) * | 2000-03-14 | 2001-09-24 | Regeneron Pharmaceuticals, Inc. | Methods of stimulating cartilage formation |
EP1603586A1 (en) * | 2003-02-19 | 2005-12-14 | Aziz Ghahary | 14-3-3 protein for prevention and treatment of fibroproliferative disorders |
JP2006524508A (ja) * | 2003-04-16 | 2006-11-02 | ワイス | 骨関連の活性を調節する新規な方法 |
-
2007
- 2007-02-15 PE PE2007000174A patent/PE20071309A1/es not_active Application Discontinuation
- 2007-02-16 EP EP07751280A patent/EP1984395A2/en not_active Withdrawn
- 2007-02-16 WO PCT/US2007/004510 patent/WO2007098198A2/en active Application Filing
- 2007-02-16 JP JP2008555419A patent/JP2009527485A/ja not_active Withdrawn
- 2007-02-16 US US12/278,710 patent/US20090047287A1/en not_active Abandoned
- 2007-02-16 KR KR1020087021261A patent/KR20080095269A/ko not_active Application Discontinuation
- 2007-02-16 AR ARP070100684A patent/AR060104A1/es not_active Application Discontinuation
- 2007-02-16 PA PA20078715601A patent/PA8715601A1/es unknown
- 2007-02-16 TW TW096106164A patent/TW200800266A/zh unknown
- 2007-02-16 BR BRPI0707864-1A patent/BRPI0707864A2/pt not_active IP Right Cessation
- 2007-02-16 AU AU2007217779A patent/AU2007217779A1/en not_active Abandoned
- 2007-02-16 CA CA002638803A patent/CA2638803A1/en not_active Abandoned
- 2007-02-16 MX MX2008010511A patent/MX2008010511A/es not_active Application Discontinuation
- 2007-02-16 RU RU2008131052/13A patent/RU2008131052A/ru not_active Application Discontinuation
-
2008
- 2008-08-05 IL IL193271A patent/IL193271A0/en unknown
- 2008-08-13 NO NO20083497A patent/NO20083497L/no not_active Application Discontinuation
- 2008-08-15 SV SV2008002997A patent/SV2009002997A/es unknown
- 2008-08-15 EC EC2008008682A patent/ECSP088682A/es unknown
- 2008-08-18 CR CR10212A patent/CR10212A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CR10212A (es) | 2008-10-03 |
KR20080095269A (ko) | 2008-10-28 |
RU2008131052A (ru) | 2010-03-27 |
ECSP088682A (es) | 2008-09-29 |
PA8715601A1 (es) | 2008-11-19 |
TW200800266A (en) | 2008-01-01 |
PE20071309A1 (es) | 2008-02-13 |
BRPI0707864A2 (pt) | 2011-05-10 |
WO2007098198A3 (en) | 2008-03-13 |
MX2008010511A (es) | 2008-11-18 |
NO20083497L (no) | 2008-10-31 |
WO2007098198A2 (en) | 2007-08-30 |
IL193271A0 (en) | 2011-08-01 |
JP2009527485A (ja) | 2009-07-30 |
SV2009002997A (es) | 2009-04-17 |
US20090047287A1 (en) | 2009-02-19 |
AU2007217779A1 (en) | 2007-08-30 |
CA2638803A1 (en) | 2007-08-30 |
EP1984395A2 (en) | 2008-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR060104A1 (es) | Modulacion de la formacion de huesos | |
CL2018000226A1 (es) | Mezcla de péptidos (divisional solicitud 201601405) | |
NO20081124L (no) | Anti-CD 3 antistoff-formuleringer | |
ECSP14001249A (es) | Inmunoenlazadores dirigidos contra el tnf | |
EA201100300A1 (ru) | Композиции и способы, предназначенные для направленного воздействия антител на белок c5 системы комплемента | |
CY1117162T1 (el) | Μεθοδος κατασκευης αντισωματος fc-ετεροδιμερικων μοριων χρησιμοποιωντας αποτελεσματα ηλεκτροστατικης καθοδηγησης | |
GT201200271A (es) | Proteínas que se unen al tnf-a | |
CY1118797T1 (el) | Ανταγωνιστες toll-ωδους υποδοχεα 3 | |
DE602004030354D1 (de) | Systeme mit wechselbaren hörnern zur herstellung von eingeschlossenen produkten | |
EA200600038A1 (ru) | Антитела, специфические в отношении склеростина, и способы увеличения минерализации кости | |
EA201690377A1 (ru) | Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения | |
ECSP077316A (es) | Compuestos imidazo-3-il-amina bicíclicos sustituidos | |
CY1114887T1 (el) | Συνθεσεις και μεθοδοι παρασκευης συνθεσης | |
CO6382161A2 (es) | Moleculas biespecificas de union a egfr/igfir | |
BR112014006390A2 (pt) | anticorpos, domínios variáveis e cadeias feitos especialmente para uso humano | |
BR112012026766A2 (pt) | métodos in vitro para gerar uma proteína heterodimérica, para a seleção de um anticorpo biespecífico e para inibir o crescimento, vetor de expressão, célula hospedeira, proteína heterodimérica, composição farmacêutica. | |
BRPI0408247A (pt) | usos de antagonistas e agonistas de il-23 e reagentes relacionados | |
CR9294A (es) | Formulaciones de polipeptido liquidas estabilizadas | |
AR113492A2 (es) | Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla | |
BR0315275A (pt) | Anticorpos que se ligam a receptor de eritropoietina | |
CR11374A (es) | Proteinas humanas de union a antigenos del gm-csf | |
MX2009008918A (es) | Activacion de celulas que presentan antigeno humano a traves de clec-6. | |
EA201291180A1 (ru) | Композиции и способы применения терапевтических антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6) | |
MX2020004712A (es) | Vesiculas extracelulares modificadas geneticamente con proteinas. | |
ATE539089T1 (de) | Cyclische rezeptor-assoziierte-proteine (rap)- peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |